Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH

NCT04131907 is registered in ClinicalTrials.gov with Urotronic Inc. as lead sponsor.

NCT NCT04131907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04131907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH
Lead sponsor
Urotronic Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 5, 2020
Completion date
May 31, 2027
Enrollment
162 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia